Summary
Gross Cystic Disease Fluid Protein (GCDFP-15) is a 60,000 dalton glycoprotein isolated from human breast cyst fluid, composed of four 15,000 dalton monomers. Carbohydrate analysis indicates that each monomer has a single carbohydrate chain of the complex type. GCDFP-15 intravenously injected into rats showed a rapid circulatory clearance, the rate of clearance being faster in female animals [t1/2 = 12.8 (± 2.0) min. females, and 16.7 (± 2.6) min. males]. The major organs of clearance were the liver (70%) and kidneys (15%). Immunoperoxidase staining showed localization in Kupffer cells and the proximal convoluted tubules of the kidney. Removal of sialic acid from GCDFP-15 resulted in a more rapid clearance (t1/2 = 2.2 min) by the liver (85%). This clearance was inhibited by coinjection of asialo alpha1 acid glycoprotein. About 3% of GCDFP-15 was excreted in bile with a transit time through the liver of 38 min. Examination of the uptake of GCDFP-15 by isolated rat Kupffer cells showed that yeast mannan, fucosylated BSA, and carcinoembryonic antigen (CEA) failed to inhibit uptake, though the binding of GCDFP-15 was clearly saturable. This suggests that a novel receptor system on the rat Kupffer cell may be responsible for GCDFP-15 clearance.
References
Haagensen D, Dilley W, Cox C, Griannola J, Wells S: Monitoring of hormonal therapy in patients with metastatic breast carcinoma by plasma marker protein profiles. Surg Forum 29: 162–163, 1978
Haagensen DE, Mazoujian G, Dilley WG, Peterson CE, Kister SJ, Wells SA: Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J Natl Cancer Inst 62: 239–247, 1979
Haagensen D, Kister S, Panick J, Griannola J, Hansen H, Wells S: Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma. Cancer 42: 1646–1651, 1978
Haagensen D, Gall S, Brazy J, Giannola J, Wells S: Analysis of amniotic fluid, maternal plasma, and cord blood for human breast gross cystic disease fluid proteins. Amer J Obstet Gynecol 138: 25–32, 1980
Estabrook A, Kister S, Hardy M, Grossbard L, Oster M, Davis S, Mazoujian G, Haagensen D: Nonhuman primate anti-gross cystic disease fluid protein 15 antibody infusion in four women with metastatic breast carcinoma. Cancer Immunol Immunother 25: 143–147, 1986
Haagensen D: Biochemical relationship between gross cystic disease and breast carcinoma.In: Haagensen C, Bodian C, Haagensen D (eds) Breast Carcinoma: Risk and Detection. WB Saunders, Philadelphia, 1981, pp 300–338
Thomas P, Hems DA: The hepatic clearance of circulating native and asialo carcinoembryonic antigen by the rat. Biochem Biophys Res Commun 67: 1205–1209, 1975
Thomas P, Zamcheck N, Rogers AE, Fox J: Plasma clearance of carcinoembryonic antigen and asialo carcinoem-bryonic antigen by the nutritionally deficient rhesus monkey.In: Statland BE, Winkel P (eds) Clinics in Laboratory Medicine, Vol 2(3), Symposium on Laboratory Measurements in Malignant Disease. WB Saunders, Philadelphia, 1982, pp 459–467
Thomas P, Zamcheck N: Role of the liver in clearance and excretion of circulating carcinoembryonic antigen (CEA). Dig Dis and Sci 28(3): 216–224, 1983
Toth CA, Thomas P, Broitman SA, Zamcheck N: A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat. Biochem J 204: 377–381, 1982
Toth CA, Thomas P, Broitman SA, Zamcheck N: Receptor mediated endocytosis of carcinoembryonic antigen by rat liver Kupffer cells. Cancer Res 45: 392–397, 1985
Loewenstein M, Zamcheck N: Clinical trends and topics: Carcinoembryonic antigen and the liver. Gastroenterology 72: 161–167, 1977
Greenwood F, Hunter W, Glover J: The preparation of131I labeled human growth hormone of high specific radioactivity. Biochem J 89: 114–123, 1963
Saravis C, Zamcheck N: Isoelectric focussing in agarose. J Immunol Meth 29: 91–96, 1979
Reinhold V: Gas-liquid chromatographic analysis of constituent carbohydrates on glycoproteins. Adv Enzymol 25: 244–249, 1972
Whitehead PH, Sammons HG: A simple technique for the isolation of orosomucoid from normal and pathological sera. Biochem Biophys Acta 124: 209–211, 1966
Warren L: Thiobarbituric acid assay of sialic acid. J Biol Chem 234: 1971–1975, 1959
Mazoujian G, Pinkus G, Davis S, Haagensen D: Immuno-histochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. Am J Path 110: 105–112, 1983
Seglen P: Preparation of rat liver cells III. Enzymatic requirements for tissue dispersion. Expt Cell Res 82: 391–398, 1973
Kaplow L: Cytochemical identification of mononuclear macrophages.In: Herscowitz (ed) Manual of Macrophage Methodology. Marcel Dekker, New York, 1981, pp 199–207
Thomas P: Studies on the mechanisms of biliary excretion of circulating glycoproteins. Biochem J 192: 837–843, 1980
Thomas P, Toth CA, Zamcheck N: The mechanism of biliary excretion of alpha1acid glycoprotein in the rat: Evidence for a molecular weight dependant nonreceptor mediated pathway. Hepatology 2: 800–803, 1982
Thomas P, Birbeck M, Cartwright P: A radioautographic study of the hepatic uptake of circulating carcinoembryonic antigen by the mouse. Biochem Soc Trans 5: 312–313, 1977
Wada T, Ohara H, Watanabe K, Kinoshita H, Yachi A: Autoradiographic study on site of uptake of the haptoglo-bin-hemoglobin complex. J Ret Soc 8: 185–192, 1970
Ashwell G, Morell A: The role of surface carbohydrates in hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Rel Areas Med Biol 41: 99–127, 1974
Achord D, Brot F, Bell C, Sly W: Human B-glucuronidase:in vivo clearance andin vitro uptake by a glycoprotein recognition system in reticuloendothelial cells. Cell 15: 269–274, 1978
Maynard Y, Baenziger J: Oligosaccharide specific endocytosis by isolated rat hepatic reticuloendothelial cells. J Biol Chem 256: 8063–8068, 1981
Steer C, Kusiak J, Brady R, Jones E: Selective uptake of human β-hexosaminidase A by a specific glycoprotein recognition system on sinusoidal cells. Proc Natl Acad Sci (USA) 76: 2774–2778, 1979
Prieels J, Pizzo S, Glasgow L, Paulson J, Hill R: Hepatic receptor that specifically binds oligosaccharides containing fucosyl α1,3,-N-acetylglucosamine linkages. Proc Natl Acad Sci (USA) 75: 2215–2219, 1978
Stahl P, Gordon S: Expression of mannosyl-fucosyl receptor for endocytosis on cultured primary macrophages and their hybrids. J Cell Biol 93: 49–55, 1982
Ashwell G, Steer C: Hepatic recognition and catabolism of serum glycoproteins. JAMA 246: 2358, 1981
Thomas P, Summers JW: The biliary excretion of circulating asialo glycoproteins in the rat. Biochem Biophys Res Commun 80: 335–339, 1978
Haagensen D, Wells S: Plasma human breast gross cystic disease fluid assay.In: Herberman R (ed) Compendium of Assays for Immunodiagnosis of Human Cancer. Elsevier-North Holland, New York, 1979, p 397
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Toth, C.A., Haagensen, D.E., Davis, S. et al. Hepatic clearance and metabolism in the rat of a human breast cancer associated glycoprotein (GCDFP-15). Breast Cancer Res Tr 12, 235–243 (1988). https://doi.org/10.1007/BF01805944
Issue Date:
DOI: https://doi.org/10.1007/BF01805944